BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 79 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,098,000 | +38.6% | 907,032 | 0.0% | 65.36% | +88.1% |
| Q2 2022 | $15,220,000 | -62.2% | 907,032 | -1.1% | 34.74% | -28.5% |
| Q1 2022 | $40,248,000 | -28.0% | 917,218 | -0.1% | 48.61% | +34.6% |
| Q4 2021 | $55,888,000 | -6.5% | 918,154 | -36.1% | 36.13% | +23.6% |
| Q3 2021 | $59,742,000 | +2.7% | 1,436,456 | -25.0% | 29.23% | +15.4% |
| Q2 2021 | $58,147,000 | +1.6% | 1,915,274 | 0.0% | 25.33% | +18.2% |
| Q1 2021 | $57,209,000 | +66.4% | 1,915,274 | 0.0% | 21.43% | +29.4% |
| Q4 2020 | $34,379,000 | -5.8% | 1,915,274 | 0.0% | 16.56% | -10.4% |
| Q3 2020 | $36,486,000 | +21.0% | 1,915,274 | 0.0% | 18.48% | -11.6% |
| Q2 2020 | $30,147,000 | +15.3% | 1,915,274 | 0.0% | 20.91% | -4.6% |
| Q1 2020 | $26,143,000 | +44.7% | 1,915,274 | 0.0% | 21.93% | +100.4% |
| Q4 2019 | $18,061,000 | -17.2% | 1,915,274 | 0.0% | 10.94% | -28.6% |
| Q3 2019 | $21,815,000 | +13.2% | 1,915,274 | 0.0% | 15.32% | +18.5% |
| Q2 2019 | $19,268,000 | – | 1,915,274 | – | 12.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,915,274 | $57,209,000 | 21.43% |
| Atlas Venture Advisors, Inc. | 612,696 | $18,301,000 | 3.38% |
| Logos Global Management LP | 800,000 | $23,896,000 | 2.33% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,957,961 | $58,484,000 | 1.28% |
| Ghost Tree Capital, LLC | 150,000 | $4,481,000 | 1.05% |
| Parkman Healthcare Partners LLC | 75,454 | $2,254,000 | 0.52% |
| MOODY ALDRICH PARTNERS LLC | 74,060 | $2,212,000 | 0.32% |
| Point72 Asset Management, L.P. | 1,577,493 | $47,120,000 | 0.22% |
| Eventide Asset Management | 411,838 | $12,302,000 | 0.18% |
| SAMLYN CAPITAL, LLC | 437,728 | $13,076,000 | 0.18% |